 Tunuguntla Kumar
Concepts (426)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Follicle Stimulating Hormone | 32 | 2022 | 216 | 5.230 |
Why?
| | Follicle Stimulating Hormone, beta Subunit | 22 | 2022 | 28 | 3.620 |
Why?
| | Luteinizing Hormone | 12 | 2022 | 173 | 2.110 |
Why?
| | Reproduction | 10 | 2019 | 189 | 1.820 |
Why?
| | Mice, Knockout | 36 | 2022 | 2664 | 1.560 |
Why?
| | Gonadotrophs | 3 | 2015 | 21 | 1.540 |
Why?
| | Ovary | 17 | 2018 | 205 | 1.470 |
Why?
| | Testis | 13 | 2016 | 144 | 1.470 |
Why?
| | Pituitary Gland | 8 | 2020 | 163 | 1.360 |
Why?
| | Mice, Transgenic | 26 | 2020 | 2012 | 1.170 |
Why?
| | Mice | 76 | 2022 | 15446 | 1.050 |
Why?
| | Ribonuclease III | 2 | 2015 | 33 | 1.040 |
Why?
| | DEAD-box RNA Helicases | 2 | 2015 | 56 | 1.020 |
Why?
| | Gonadotropins | 5 | 2022 | 37 | 0.990 |
Why?
| | Fertility | 8 | 2015 | 135 | 0.980 |
Why?
| | Animals | 85 | 2022 | 33152 | 0.980 |
Why?
| | Sertoli Cells | 8 | 2017 | 25 | 0.880 |
Why?
| | Receptors, FSH | 6 | 2018 | 9 | 0.870 |
Why?
| | Follicle Stimulating Hormone, Human | 2 | 2016 | 11 | 0.860 |
Why?
| | Biology | 2 | 2019 | 80 | 0.770 |
Why?
| | Inhibins | 13 | 2008 | 46 | 0.750 |
Why?
| | Protein Processing, Post-Translational | 3 | 2019 | 408 | 0.740 |
Why?
| | Signal Transduction | 13 | 2018 | 4688 | 0.730 |
Why?
| | Spermatogenesis | 4 | 2017 | 53 | 0.710 |
Why?
| | Laboratory Personnel | 1 | 2019 | 3 | 0.680 |
Why?
| | Genetics | 1 | 2019 | 28 | 0.670 |
Why?
| | Luteinizing Hormone, beta Subunit | 3 | 2007 | 4 | 0.630 |
Why?
| | Oogenesis | 1 | 2017 | 27 | 0.600 |
Why?
| | Ovarian Follicle | 8 | 2019 | 61 | 0.600 |
Why?
| | Activin Receptors, Type II | 3 | 2005 | 9 | 0.560 |
Why?
| | Infertility | 3 | 2005 | 45 | 0.560 |
Why?
| | Gene Expression Regulation | 11 | 2019 | 2435 | 0.550 |
Why?
| | Recombinant Proteins | 4 | 2016 | 1302 | 0.550 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 219 | 0.520 |
Why?
| | PAX7 Transcription Factor | 1 | 2014 | 9 | 0.510 |
Why?
| | Integrases | 1 | 2015 | 122 | 0.510 |
Why?
| | Models, Genetic | 1 | 2018 | 592 | 0.510 |
Why?
| | Epididymis | 2 | 2012 | 9 | 0.480 |
Why?
| | Gonadotropin-Releasing Hormone | 6 | 2022 | 193 | 0.470 |
Why?
| | Female | 52 | 2022 | 61261 | 0.460 |
Why?
| | Spermatozoa | 2 | 2010 | 91 | 0.460 |
Why?
| | Male | 47 | 2020 | 57474 | 0.450 |
Why?
| | Steroids | 4 | 2018 | 153 | 0.440 |
Why?
| | Glycoproteins | 7 | 2004 | 317 | 0.430 |
Why?
| | Infertility, Female | 6 | 2003 | 94 | 0.430 |
Why?
| | Gene Expression | 10 | 2020 | 1482 | 0.430 |
Why?
| | Infertility, Male | 4 | 2001 | 61 | 0.430 |
Why?
| | Granulosa Cells | 4 | 2019 | 30 | 0.430 |
Why?
| | Cyclin D3 | 1 | 2012 | 4 | 0.420 |
Why?
| | Cyclin D2 | 1 | 2012 | 4 | 0.420 |
Why?
| | Hypogonadism | 4 | 2014 | 77 | 0.420 |
Why?
| | Cyclin D1 | 1 | 2012 | 61 | 0.410 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 4 | 2006 | 22 | 0.410 |
Why?
| | Inhibin-beta Subunits | 3 | 2007 | 5 | 0.400 |
Why?
| | Chorionic Gonadotropin | 4 | 2007 | 80 | 0.390 |
Why?
| | Real-Time Polymerase Chain Reaction | 4 | 2016 | 333 | 0.390 |
Why?
| | Stem Cells | 3 | 2014 | 556 | 0.380 |
Why?
| | History, 20th Century | 3 | 2019 | 281 | 0.370 |
Why?
| | Molecular Imaging | 1 | 2010 | 54 | 0.370 |
Why?
| | Models, Animal | 3 | 2006 | 349 | 0.370 |
Why?
| | Plasmodium berghei | 4 | 2016 | 7 | 0.370 |
Why?
| | Biological Evolution | 1 | 2014 | 439 | 0.360 |
Why?
| | Disease Models, Animal | 6 | 2012 | 3676 | 0.360 |
Why?
| | Embryonic Development | 1 | 2010 | 117 | 0.360 |
Why?
| | Aging | 4 | 2018 | 1675 | 0.350 |
Why?
| | Anti-Mullerian Hormone | 4 | 2019 | 51 | 0.350 |
Why?
| | Oocytes | 3 | 2018 | 190 | 0.350 |
Why?
| | Gonadotropins, Pituitary | 2 | 2005 | 22 | 0.330 |
Why?
| | Osteoporosis | 3 | 2017 | 226 | 0.320 |
Why?
| | Glycosylation | 3 | 2019 | 129 | 0.320 |
Why?
| | Pituitary Gland, Anterior | 4 | 1998 | 45 | 0.320 |
Why?
| | History, 21st Century | 2 | 2019 | 170 | 0.310 |
Why?
| | Androgens | 4 | 2012 | 167 | 0.290 |
Why?
| | Ovulation | 3 | 2014 | 41 | 0.280 |
Why?
| | Receptors, Gonadotropin | 1 | 2005 | 1 | 0.270 |
Why?
| | Testicular Neoplasms | 3 | 2008 | 95 | 0.270 |
Why?
| | Antimalarials | 3 | 2016 | 24 | 0.270 |
Why?
| | Sexual Behavior, Animal | 1 | 2005 | 50 | 0.260 |
Why?
| | Mutation | 9 | 2008 | 3435 | 0.260 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2006 | 363 | 0.260 |
Why?
| | Transgenes | 4 | 2016 | 174 | 0.260 |
Why?
| | Ovarian Neoplasms | 4 | 2008 | 420 | 0.250 |
Why?
| | Mice, Inbred C57BL | 16 | 2013 | 4887 | 0.250 |
Why?
| | Base Sequence | 9 | 2018 | 2148 | 0.250 |
Why?
| | MicroRNAs | 3 | 2017 | 633 | 0.240 |
Why?
| | RNA, Messenger | 12 | 2020 | 2657 | 0.240 |
Why?
| | Receptors, LHRH | 1 | 2003 | 17 | 0.240 |
Why?
| | Hormones | 1 | 2004 | 135 | 0.240 |
Why?
| | Freeze Drying | 1 | 2004 | 74 | 0.240 |
Why?
| | Testosterone | 7 | 2013 | 350 | 0.240 |
Why?
| | Receptors, Growth Factor | 2 | 2001 | 49 | 0.240 |
Why?
| | Liver | 4 | 2018 | 1803 | 0.220 |
Why?
| | Humans | 28 | 2022 | 118251 | 0.220 |
Why?
| | Leydig Cells | 4 | 2004 | 12 | 0.220 |
Why?
| | Adiposity | 2 | 2018 | 508 | 0.220 |
Why?
| | Blotting, Western | 2 | 2016 | 1186 | 0.210 |
Why?
| | Activins | 9 | 2020 | 26 | 0.210 |
Why?
| | Models, Biological | 4 | 2018 | 1701 | 0.210 |
Why?
| | Pharmaceutical Preparations | 1 | 2004 | 168 | 0.210 |
Why?
| | Genes, Dominant | 2 | 2013 | 96 | 0.200 |
Why?
| | Mice, Mutant Strains | 7 | 2013 | 279 | 0.200 |
Why?
| | gamma-Glutamyltransferase | 1 | 2000 | 43 | 0.190 |
Why?
| | Forkhead Box Protein L2 | 1 | 2020 | 2 | 0.190 |
Why?
| | Promoter Regions, Genetic | 4 | 2018 | 1157 | 0.180 |
Why?
| | Smad4 Protein | 1 | 2020 | 37 | 0.180 |
Why?
| | Biocompatible Materials | 1 | 2004 | 378 | 0.180 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 2 | 2019 | 141 | 0.180 |
Why?
| | Phenotype | 7 | 2007 | 2937 | 0.180 |
Why?
| | Receptors, Androgen | 3 | 2006 | 132 | 0.180 |
Why?
| | Genes, Lethal | 1 | 1999 | 25 | 0.180 |
Why?
| | Bone Morphogenetic Protein 15 | 2 | 2018 | 2 | 0.180 |
Why?
| | Growth Differentiation Factor 9 | 2 | 2018 | 4 | 0.180 |
Why?
| | Spiro Compounds | 1 | 2018 | 10 | 0.170 |
Why?
| | Genes, Tumor Suppressor | 2 | 1998 | 77 | 0.170 |
Why?
| | Oxidants | 1 | 1999 | 119 | 0.170 |
Why?
| | Antigens, Polyomavirus Transforming | 1 | 1998 | 14 | 0.170 |
Why?
| | Receptors, Steroid | 1 | 2019 | 54 | 0.170 |
Why?
| | Oligospermia | 2 | 2013 | 9 | 0.160 |
Why?
| | Bone and Bones | 3 | 2013 | 288 | 0.160 |
Why?
| | Esters | 1 | 2018 | 61 | 0.160 |
Why?
| | Neoplasms, Experimental | 2 | 1998 | 156 | 0.160 |
Why?
| | Texas | 1 | 2019 | 186 | 0.160 |
Why?
| | MDS1 and EVI1 Complex Locus Protein | 1 | 2018 | 6 | 0.160 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 110 | 0.160 |
Why?
| | Benzene Derivatives | 2 | 2012 | 13 | 0.160 |
Why?
| | Placentation | 1 | 2018 | 42 | 0.160 |
Why?
| | Bone Development | 1 | 2018 | 53 | 0.150 |
Why?
| | Gene Transfer Techniques | 1 | 1998 | 153 | 0.150 |
Why?
| | Meiosis | 1 | 2017 | 61 | 0.150 |
Why?
| | Oligopeptides | 1 | 1999 | 250 | 0.150 |
Why?
| | Phosphorylation | 3 | 2019 | 1622 | 0.150 |
Why?
| | Thermogenesis | 1 | 2017 | 43 | 0.150 |
Why?
| | Aromatase | 3 | 2006 | 31 | 0.150 |
Why?
| | Gonads | 3 | 2007 | 29 | 0.150 |
Why?
| | Genital Neoplasms, Male | 1 | 1996 | 6 | 0.150 |
Why?
| | Pituitary Neoplasms | 1 | 1998 | 165 | 0.150 |
Why?
| | Gene Targeting | 3 | 2007 | 80 | 0.150 |
Why?
| | Time Factors | 4 | 2016 | 6368 | 0.150 |
Why?
| | Osteoclasts | 2 | 2006 | 36 | 0.140 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2016 | 12 | 0.140 |
Why?
| | Adenoma | 1 | 1998 | 191 | 0.140 |
Why?
| | Growth Substances | 4 | 1998 | 136 | 0.140 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 175 | 0.140 |
Why?
| | Microtubule-Associated Proteins | 1 | 2017 | 186 | 0.140 |
Why?
| | Cattle | 2 | 2015 | 974 | 0.140 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 1 | 2016 | 144 | 0.130 |
Why?
| | Genital Neoplasms, Female | 1 | 1996 | 72 | 0.130 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 224 | 0.130 |
Why?
| | Phagocytosis | 1 | 2017 | 360 | 0.130 |
Why?
| | Cell Cycle | 3 | 2018 | 547 | 0.130 |
Why?
| | Wasting Syndrome | 3 | 2000 | 11 | 0.130 |
Why?
| | Metallothionein | 4 | 2003 | 24 | 0.120 |
Why?
| | Microscopy, Immunoelectron | 1 | 2014 | 45 | 0.120 |
Why?
| | Triclosan | 2 | 2011 | 9 | 0.120 |
Why?
| | Superovulation | 3 | 2006 | 8 | 0.120 |
Why?
| | Pituitary Hormones | 1 | 2013 | 16 | 0.120 |
Why?
| | Uterus | 3 | 2004 | 197 | 0.120 |
Why?
| | Autophagy | 1 | 2017 | 312 | 0.120 |
Why?
| | Molecular Sequence Data | 4 | 2006 | 2855 | 0.120 |
Why?
| | Osteocalcin | 1 | 2013 | 35 | 0.120 |
Why?
| | Pregnancy | 4 | 2018 | 5671 | 0.120 |
Why?
| | Thioctic Acid | 1 | 2013 | 8 | 0.110 |
Why?
| | Dihydrotestosterone | 1 | 1993 | 39 | 0.110 |
Why?
| | Adipose Tissue | 1 | 2017 | 595 | 0.110 |
Why?
| | Malaria | 2 | 2011 | 60 | 0.110 |
Why?
| | Bone Resorption | 3 | 2013 | 80 | 0.110 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 314 | 0.110 |
Why?
| | Organ Specificity | 3 | 2012 | 274 | 0.110 |
Why?
| | Malaria, Falciparum | 1 | 2012 | 31 | 0.110 |
Why?
| | Testicular Hormones | 2 | 2003 | 9 | 0.110 |
Why?
| | Protozoan Proteins | 2 | 2013 | 67 | 0.110 |
Why?
| | Urea | 1 | 2012 | 77 | 0.110 |
Why?
| | Estradiol | 2 | 2008 | 473 | 0.110 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2017 | 155 | 0.110 |
Why?
| | Biomedical Research | 1 | 2018 | 600 | 0.110 |
Why?
| | Rats | 4 | 2014 | 5339 | 0.110 |
Why?
| | Apoptosis | 2 | 2017 | 2461 | 0.100 |
Why?
| | Host-Parasite Interactions | 1 | 2013 | 110 | 0.100 |
Why?
| | Sex Factors | 3 | 2006 | 1765 | 0.100 |
Why?
| | Castration | 2 | 2003 | 14 | 0.100 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 108 | 0.100 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2013 | 192 | 0.100 |
Why?
| | Pancreas | 1 | 2013 | 281 | 0.100 |
Why?
| | Epithelium | 1 | 2012 | 303 | 0.100 |
Why?
| | Analysis of Variance | 1 | 2014 | 1288 | 0.100 |
Why?
| | Ovariectomy | 3 | 2017 | 124 | 0.100 |
Why?
| | Sperm Motility | 1 | 2010 | 28 | 0.100 |
Why?
| | Anti-Infective Agents, Local | 1 | 2011 | 42 | 0.090 |
Why?
| | Osteoblasts | 2 | 2013 | 115 | 0.090 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 2010 | 46 | 0.090 |
Why?
| | Seminal Vesicles | 2 | 2000 | 8 | 0.090 |
Why?
| | Amino Acid Sequence | 4 | 2013 | 2063 | 0.090 |
Why?
| | Radioimmunoassay | 2 | 2004 | 164 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2010 | 219 | 0.090 |
Why?
| | Adipocytes | 3 | 2018 | 195 | 0.090 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2006 | 285 | 0.090 |
Why?
| | Neoplasm Proteins | 2 | 2018 | 398 | 0.090 |
Why?
| | Orchiectomy | 3 | 1995 | 57 | 0.090 |
Why?
| | Homozygote | 3 | 1999 | 189 | 0.090 |
Why?
| | Pseudopregnancy | 1 | 2009 | 3 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2010 | 287 | 0.090 |
Why?
| | Microinjections | 1 | 2009 | 83 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2009 | 1004 | 0.080 |
Why?
| | Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 25 | 0.080 |
Why?
| | Hyperphagia | 1 | 2008 | 31 | 0.080 |
Why?
| | Longevity | 2 | 2008 | 150 | 0.080 |
Why?
| | Plasmodium falciparum | 1 | 2008 | 33 | 0.080 |
Why?
| | Microscopy, Electron | 3 | 2013 | 412 | 0.080 |
Why?
| | Genes, Reporter | 1 | 2009 | 268 | 0.080 |
Why?
| | Kinetics | 2 | 2018 | 1623 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2018 | 1967 | 0.080 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 2 | 2006 | 14 | 0.080 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 2837 | 0.070 |
Why?
| | Ribonucleoproteins, Small Nucleolar | 1 | 2006 | 3 | 0.070 |
Why?
| | Spermatogonia | 1 | 2006 | 11 | 0.070 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2006 | 67 | 0.070 |
Why?
| | 3' Flanking Region | 1 | 2006 | 6 | 0.070 |
Why?
| | Codon, Terminator | 1 | 2006 | 21 | 0.070 |
Why?
| | Preoptic Area | 1 | 2005 | 6 | 0.070 |
Why?
| | Copulation | 1 | 2005 | 5 | 0.070 |
Why?
| | Penis | 1 | 2005 | 37 | 0.070 |
Why?
| | Bone Marrow Cells | 1 | 2006 | 273 | 0.070 |
Why?
| | Genes | 2 | 1995 | 227 | 0.070 |
Why?
| | Mice, Inbred ICR | 2 | 2003 | 111 | 0.070 |
Why?
| | Cyclic AMP | 2 | 2003 | 240 | 0.070 |
Why?
| | Olfactory Pathways | 1 | 2005 | 56 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1995 | 541 | 0.060 |
Why?
| | Nitric Oxide Synthase | 1 | 2005 | 226 | 0.060 |
Why?
| | CHO Cells | 1 | 2004 | 142 | 0.060 |
Why?
| | Gene Deletion | 4 | 2013 | 359 | 0.060 |
Why?
| | Protein Subunits | 3 | 2014 | 210 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2012 | 2262 | 0.060 |
Why?
| | Genetic Markers | 1 | 2005 | 347 | 0.060 |
Why?
| | Thyrotropin | 1 | 2004 | 104 | 0.060 |
Why?
| | Cricetinae | 1 | 2004 | 261 | 0.060 |
Why?
| | Hypothyroidism | 1 | 2004 | 68 | 0.060 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2006 | 317 | 0.060 |
Why?
| | Biological Assay | 1 | 2004 | 122 | 0.060 |
Why?
| | Peptides | 3 | 2000 | 879 | 0.060 |
Why?
| | DNA Damage | 1 | 2006 | 356 | 0.060 |
Why?
| | Reference Values | 1 | 2005 | 770 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2004 | 196 | 0.060 |
Why?
| | Fibrin | 1 | 2004 | 58 | 0.060 |
Why?
| | Serum | 1 | 2004 | 62 | 0.060 |
Why?
| | Thecoma | 1 | 2003 | 2 | 0.060 |
Why?
| | Hypothalamus | 1 | 2003 | 155 | 0.060 |
Why?
| | Dimerization | 1 | 2003 | 183 | 0.050 |
Why?
| | Organ Size | 3 | 2013 | 460 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 980 | 0.050 |
Why?
| | Phylogeny | 1 | 2006 | 817 | 0.050 |
Why?
| | United States | 1 | 2018 | 12488 | 0.050 |
Why?
| | Protein Binding | 2 | 2018 | 1969 | 0.050 |
Why?
| | Growth Inhibitors | 1 | 2001 | 43 | 0.050 |
Why?
| | Sperm Count | 1 | 2001 | 16 | 0.050 |
Why?
| | Wound Healing | 1 | 2004 | 270 | 0.050 |
Why?
| | Cells, Cultured | 3 | 2017 | 4044 | 0.050 |
Why?
| | In Situ Nick-End Labeling | 1 | 2001 | 124 | 0.050 |
Why?
| | Protein Conformation | 1 | 2004 | 848 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2006 | 1159 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2018 | 418 | 0.050 |
Why?
| | Sex Characteristics | 2 | 1998 | 667 | 0.050 |
Why?
| | Cell Line | 5 | 2017 | 2693 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2004 | 306 | 0.050 |
Why?
| | Obesity | 2 | 2017 | 2715 | 0.050 |
Why?
| | Liver Regeneration | 1 | 2000 | 34 | 0.050 |
Why?
| | Growth Hormone | 1 | 2000 | 107 | 0.050 |
Why?
| | Motor Activity | 1 | 2005 | 664 | 0.050 |
Why?
| | Growth Disorders | 1 | 2000 | 77 | 0.050 |
Why?
| | Sequence Analysis, DNA | 2 | 2013 | 748 | 0.050 |
Why?
| | Tissue Culture Techniques | 1 | 2020 | 66 | 0.050 |
Why?
| | Homeostasis | 1 | 2003 | 589 | 0.050 |
Why?
| | Follistatin | 4 | 2001 | 12 | 0.050 |
Why?
| | tert-Butylhydroperoxide | 1 | 1999 | 10 | 0.040 |
Why?
| | Lethal Dose 50 | 1 | 1999 | 12 | 0.040 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1322 | 0.040 |
Why?
| | Acetylcysteine | 1 | 2000 | 147 | 0.040 |
Why?
| | Mutagens | 1 | 1999 | 17 | 0.040 |
Why?
| | Cysteine | 1 | 2000 | 184 | 0.040 |
Why?
| | Fetal Death | 1 | 1999 | 53 | 0.040 |
Why?
| | Crosses, Genetic | 1 | 1999 | 138 | 0.040 |
Why?
| | 3T3-L1 Cells | 1 | 2018 | 35 | 0.040 |
Why?
| | Urinary Tract | 1 | 1999 | 40 | 0.040 |
Why?
| | Vibrissae | 1 | 1998 | 11 | 0.040 |
Why?
| | Cell Shape | 1 | 2018 | 57 | 0.040 |
Why?
| | Smad3 Protein | 1 | 2018 | 47 | 0.040 |
Why?
| | Smad2 Protein | 1 | 2018 | 39 | 0.040 |
Why?
| | Hydrolysis | 1 | 2018 | 176 | 0.040 |
Why?
| | Immunohistochemistry | 2 | 2004 | 1681 | 0.040 |
Why?
| | Curcumin | 1 | 2018 | 33 | 0.040 |
Why?
| | Histone Code | 1 | 2018 | 29 | 0.040 |
Why?
| | Embryonic and Fetal Development | 2 | 1995 | 94 | 0.040 |
Why?
| | Fluorescence | 1 | 2018 | 159 | 0.040 |
Why?
| | Gene Expression Profiling | 2 | 2017 | 1590 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2018 | 1161 | 0.040 |
Why?
| | Snail Family Transcription Factors | 1 | 2018 | 21 | 0.040 |
Why?
| | Spectrometry, Fluorescence | 1 | 2018 | 173 | 0.040 |
Why?
| | Brain Stem | 1 | 1998 | 104 | 0.040 |
Why?
| | Acetylation | 1 | 2018 | 216 | 0.040 |
Why?
| | Adipose Tissue, Beige | 1 | 2017 | 2 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2017 | 16 | 0.040 |
Why?
| | Isoenzymes | 1 | 1998 | 297 | 0.040 |
Why?
| | Gonadotropins, Equine | 1 | 1997 | 3 | 0.040 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2017 | 59 | 0.040 |
Why?
| | DNA | 2 | 1995 | 1385 | 0.040 |
Why?
| | Haploinsufficiency | 1 | 2017 | 46 | 0.040 |
Why?
| | Adipose Tissue, White | 1 | 2017 | 35 | 0.040 |
Why?
| | Cell Death | 1 | 2018 | 336 | 0.040 |
Why?
| | Polycystic Ovary Syndrome | 1 | 1999 | 156 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 312 | 0.040 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2018 | 341 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 1998 | 338 | 0.040 |
Why?
| | Tritium | 1 | 2016 | 70 | 0.040 |
Why?
| | Neoplasm Invasiveness | 1 | 2018 | 460 | 0.040 |
Why?
| | Uridine | 1 | 2016 | 30 | 0.040 |
Why?
| | Inhibitory Concentration 50 | 1 | 2016 | 81 | 0.030 |
Why?
| | Genes, Retinoblastoma | 1 | 1995 | 9 | 0.030 |
Why?
| | Growth | 1 | 1996 | 58 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2018 | 541 | 0.030 |
Why?
| | Cell Nucleus | 1 | 2018 | 577 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1995 | 66 | 0.030 |
Why?
| | RNA Interference | 1 | 2017 | 459 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2017 | 247 | 0.030 |
Why?
| | Genes, p53 | 1 | 1995 | 64 | 0.030 |
Why?
| | Cell Differentiation | 4 | 2006 | 1746 | 0.030 |
Why?
| | Blotting, Northern | 1 | 1995 | 194 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2016 | 369 | 0.030 |
Why?
| | Down-Regulation | 1 | 2018 | 623 | 0.030 |
Why?
| | Hemorrhage | 1 | 1999 | 606 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 1995 | 367 | 0.030 |
Why?
| | Antibodies | 1 | 2017 | 381 | 0.030 |
Why?
| | Introns | 1 | 1995 | 233 | 0.030 |
Why?
| | Exons | 1 | 1995 | 306 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 1996 | 360 | 0.030 |
Why?
| | Oxygen Consumption | 1 | 2017 | 585 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1514 | 0.030 |
Why?
| | Adenosine | 1 | 2016 | 211 | 0.030 |
Why?
| | Mice, 129 Strain | 1 | 2013 | 75 | 0.030 |
Why?
| | Body Weight | 2 | 2008 | 923 | 0.030 |
Why?
| | Desmocollins | 1 | 2012 | 2 | 0.030 |
Why?
| | Immunoblotting | 1 | 1993 | 304 | 0.030 |
Why?
| | DNA Primers | 1 | 2013 | 532 | 0.030 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 275 | 0.030 |
Why?
| | Mice, Inbred C3H | 2 | 2006 | 249 | 0.030 |
Why?
| | Saccharomyces cerevisiae | 1 | 2016 | 494 | 0.030 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1082 | 0.030 |
Why?
| | Species Specificity | 1 | 1993 | 559 | 0.030 |
Why?
| | Drug Discovery | 1 | 2012 | 124 | 0.030 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2013 | 194 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2018 | 1056 | 0.030 |
Why?
| | Survival Analysis | 2 | 2008 | 1262 | 0.030 |
Why?
| | Mitochondria | 1 | 2017 | 785 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2012 | 181 | 0.020 |
Why?
| | Genetic Association Studies | 1 | 2013 | 355 | 0.020 |
Why?
| | Plasmodium | 1 | 2011 | 18 | 0.020 |
Why?
| | Rodentia | 1 | 2011 | 45 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2013 | 625 | 0.020 |
Why?
| | Flagella | 1 | 2010 | 19 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 479 | 0.020 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2003 | 810 | 0.020 |
Why?
| | NF-kappa B | 2 | 2006 | 664 | 0.020 |
Why?
| | Transcription Factors | 2 | 2012 | 1567 | 0.020 |
Why?
| | Membrane Glycoproteins | 1 | 2012 | 443 | 0.020 |
Why?
| | Cell Division | 2 | 2003 | 775 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 345 | 0.020 |
Why?
| | Parasitemia | 1 | 2008 | 9 | 0.020 |
Why?
| | RNA | 1 | 1995 | 830 | 0.020 |
Why?
| | Mutagenesis, Insertional | 1 | 2008 | 59 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2008 | 226 | 0.020 |
Why?
| | Cachexia | 1 | 2008 | 53 | 0.020 |
Why?
| | Disease Progression | 2 | 2008 | 2477 | 0.020 |
Why?
| | Corpus Luteum | 1 | 2007 | 21 | 0.020 |
Why?
| | TATA-Binding Protein Associated Factors | 1 | 2007 | 15 | 0.020 |
Why?
| | Syndrome | 1 | 2008 | 343 | 0.020 |
Why?
| | Glucose Tolerance Test | 1 | 2008 | 361 | 0.020 |
Why?
| | Transcription Factor TFIID | 1 | 2007 | 20 | 0.020 |
Why?
| | Leptin | 1 | 2008 | 228 | 0.020 |
Why?
| | Checkpoint Kinase 2 | 1 | 2006 | 23 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2006 | 14 | 0.020 |
Why?
| | Checkpoint Kinase 1 | 1 | 2006 | 27 | 0.020 |
Why?
| | Protein Phosphatase 1 | 1 | 2006 | 32 | 0.020 |
Why?
| | GTP-Binding Protein alpha Subunit, Gi2 | 1 | 2006 | 3 | 0.020 |
Why?
| | Eating | 1 | 2008 | 366 | 0.020 |
Why?
| | Ascorbic Acid | 1 | 2006 | 120 | 0.020 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2006 | 274 | 0.020 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 160 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2007 | 764 | 0.020 |
Why?
| | Centrosome | 1 | 2004 | 59 | 0.020 |
Why?
| | Protein Kinases | 1 | 2006 | 306 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2006 | 810 | 0.020 |
Why?
| | Cell Polarity | 1 | 2004 | 133 | 0.010 |
Why?
| | Energy Metabolism | 1 | 2008 | 762 | 0.010 |
Why?
| | Estrogens | 1 | 2006 | 329 | 0.010 |
Why?
| | Insulin | 1 | 2013 | 2157 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2011 | 2855 | 0.010 |
Why?
| | Cell Adhesion | 1 | 2004 | 435 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2007 | 725 | 0.010 |
Why?
| | Hypertrophy | 1 | 2003 | 121 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 42 | 0.010 |
Why?
| | Transcription Factor AP-2 | 1 | 2003 | 81 | 0.010 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2006 | 454 | 0.010 |
Why?
| | Point Mutation | 1 | 2003 | 227 | 0.010 |
Why?
| | Neoplasms | 1 | 1996 | 2160 | 0.010 |
Why?
| | Progesterone | 1 | 2003 | 242 | 0.010 |
Why?
| | Enzymes | 1 | 2001 | 66 | 0.010 |
Why?
| | Multigene Family | 1 | 2001 | 200 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2000 | 17 | 0.010 |
Why?
| | Transfection | 1 | 2003 | 887 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 1221 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 817 | 0.010 |
Why?
| | Trigeminal Nerve | 1 | 1998 | 28 | 0.010 |
Why?
| | Heterozygote | 1 | 1998 | 260 | 0.010 |
Why?
| | Liver Diseases | 1 | 2000 | 282 | 0.010 |
Why?
| | Follicular Cyst | 1 | 1996 | 1 | 0.010 |
Why?
| | Axons | 1 | 1998 | 183 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2003 | 1343 | 0.010 |
Why?
| | Activin Receptors | 1 | 1995 | 3 | 0.010 |
Why?
| | Palate | 1 | 1995 | 30 | 0.010 |
Why?
| | Mandible | 1 | 1995 | 65 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1998 | 650 | 0.010 |
Why?
| | Skull | 1 | 1995 | 127 | 0.010 |
Why?
| | Middle Aged | 1 | 2013 | 27510 | 0.010 |
Why?
| | Transforming Growth Factor beta | 1 | 1995 | 461 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 1997 | 2434 | 0.010 |
Why?
| | Adult | 1 | 2013 | 31324 | 0.010 |
Why?
| | Biomarkers | 1 | 2001 | 3567 | 0.010 |
Why?
| | Neurons | 1 | 1998 | 1340 | 0.010 |
Why?
|
|
Kumar's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|